Treatment

Infographic comparing 0.9%, 3%, 6% and 7% nebulised saline for mucus clearance and bronchiectasis.

Nebulised saline: what do 0.9%, 3%, 6% and 7% actually mean?

Patient and clinician discussing the future of aspergillosis care, with lung, blood-test and research illustrations.

The Future of Aspergillosis Care: Earlier Diagnosis, New Treatments and Personalised Support

Illustration of a T cell recognising a fungal antigen and coordinating an immune response near Aspergillus fumigatus.

Is a vaccine for chronic pulmonary aspergillosis (CPA) being developed?

Illustration showing monoclonal antibodies binding Aspergillus fumigatus and helping macrophages recognise and engulf the fungus.

Beyond antifungal drugs: could antibodies help the immune system fight Aspergillus?

Patient talking with a healthcare professional about support and treatment choices

Complementary therapies and aspergillosis: finding relief without losing sight of treatment

Patient receiving a specialist antifungal medicine delivery at home

Getting specialist antifungal medicines delivered to your home: a guide to NHS homecare

Clinician reviewing immune-suppressing medicines and blood test results alongside lung and Aspergillus imagery.

Immune-Suppressing Medicines and Aspergillosis: When Does Treatment Change the Risk?

Scientific illustration showing amphotericin B disrupting an Aspergillus fungal cell membrane during research into antifungal resistance.

Amphotericin B resistance in Aspergillus: protecting an important treatment for the future

Person reducing respiratory infection risk through ventilation, handwashing, vaccination and mask use

Respiratory Infections and Aspergillosis: Reducing Your Risk and Knowing When to Seek Help

by Beth Bradshaw

Medical illustration showing nasal polyps, inflamed lungs and dupilumab targeting inflammation throughout the connected airway

Could One Biologic Treat Nasal Polyps, Asthma and ABPA?